PDE4A and myeloid sarcoma: Understanding the role of PDE3B ablation as well as the inhibition of PDE4 and PDE5 in promoting macrophage phenotypic shifts in other pathological contexts can be implicated for controlling the phagocyte-related inflammatory responses in MS pathogenesis.